scholarly journals Structure and interactions of the C-terminal metal binding domain of Archaeoglobus fulgidus CopA

Author(s):  
Sorabh Agarwal ◽  
Deli Hong ◽  
Nirav K. Desai ◽  
Matthew H. Sazinsky ◽  
José M. Argüello ◽  
...  
Biochemistry ◽  
2007 ◽  
Vol 46 (14) ◽  
pp. 4261-4271 ◽  
Author(s):  
Angela G. Kenward ◽  
Libero J. Bartolotti ◽  
Colin S. Burns

2013 ◽  
Vol 454 (1) ◽  
pp. 147-156 ◽  
Author(s):  
Nataliya V. Dolgova ◽  
Sergiy Nokhrin ◽  
Corey H. Yu ◽  
Graham N. George ◽  
Oleg Y. Dmitriev

Human copper transporters ATP7B (Wilson's disease protein) and ATP7A (Menkes' disease protein) have been implicated in tumour resistance to cisplatin, a widely used anticancer drug. Cisplatin binds to the copper-binding sites in the N-terminal domain of ATP7B, and this binding may be an essential step of cisplatin detoxification involving copper ATPases. In the present study, we demonstrate that cisplatin and a related platinum drug carboplatin produce the same adduct following reaction with MBD2 [metal-binding domain (repeat) 2], where platinum is bound to the side chains of the cysteine residues in the CxxC copper-binding motif. This suggests the same mechanism for detoxification of both drugs by ATP7B. Platinum can also be transferred to MBD2 from copper chaperone Atox1, which was shown previously to bind cisplatin. Binding of the free cisplatin and reaction with the cisplatin-loaded Atox1 produce the same protein-bound platinum intermediate. Transfer of platinum along the copper-transport pathways in the cell may serve as a mechanism of drug delivery to its target in the cell nucleus, and explain tumour-cell resistance to cisplatin associated with the overexpression of copper transporters ATP7B and ATP7A.


2009 ◽  
Vol 387 (1) ◽  
pp. 207-218 ◽  
Author(s):  
Estevão A. Peroza ◽  
Roland Schmucki ◽  
Peter Güntert ◽  
Eva Freisinger ◽  
Oliver Zerbe

FEBS Letters ◽  
2001 ◽  
Vol 506 (3) ◽  
pp. 249-252 ◽  
Author(s):  
Nathalie Bal ◽  
Elisabeth Mintz ◽  
Florent Guillain ◽  
Patrice Catty

2006 ◽  
Vol 281 (45) ◽  
pp. 33881-33891 ◽  
Author(s):  
Elif Eren ◽  
David C. Kennedy ◽  
Michael J. Maroney ◽  
José M. Argüello

2008 ◽  
Vol 283 (22) ◽  
pp. 15142-15151 ◽  
Author(s):  
Shujian Cun ◽  
Hongyan Li ◽  
Ruiguang Ge ◽  
Marie C. M. Lin ◽  
Hongzhe Sun

Microbiology ◽  
2006 ◽  
Vol 152 (3) ◽  
pp. 709-719 ◽  
Author(s):  
Jie Qin ◽  
Lingyun Song ◽  
Hassan Brim ◽  
Michael J. Daly ◽  
Anne O. Summers

MerR, the metalloregulator of the bacterial mercury resistance (mer) operon, binds Hg(II) with high affinity. To study the mechanism of metal-induced activation, a small protein was previously engineered embodying in a single polypeptide the metal-binding domain (MBD) ordinarily formed between two monomers of MerR. Here the physiological and biochemical properties of MBD expressed on the cell surface or in the cytosol were examined, to better understand the environments in which specific metal binding can occur with this small derivative. Over 20 000 surface copies of MBD were expressed per Escherichia coli cell, with metal stoichiometries of ∼1·0 Hg(II) per MBD monomer. Cells expressing MBD on their surface in rich medium bound 6·1-fold more Hg(II) than those not expressing MBD. Although in nature cells use the entire mer operon to detoxify mercury, it was interesting to note that cells expressing only MBD survived Hg(II) challenge and recovered more quickly than cells without MBD. Cell-surface-expressed MBD bound Hg(II) preferentially even in the presence of a 22-fold molar excess of Zn(II) and when exposed to equimolar Cd(II) in addition. MBD expressed in the cystosol also afforded improved survival from Hg(II) exposure for E. coli and for the completely unrelated bacterium Deinococcus radiodurans.


2015 ◽  
Vol 34 (9) ◽  
pp. 1615-1628 ◽  
Author(s):  
Shuqin Xiang ◽  
Shanshan Feng ◽  
Yuxiu Zhang ◽  
Jinjuan Tan ◽  
Shuang Liang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document